• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

脂联素与肝胰岛素抵抗。

Adipokines and hepatic insulin resistance.

机构信息

National Center for Drug Screening and State Key Laboratory of Natural Medicines, China Pharmaceutical University, Jiangsu Province, China.

出版信息

J Diabetes Res. 2013;2013:170532. doi: 10.1155/2013/170532. Epub 2013 May 16.

DOI:10.1155/2013/170532
PMID:23762871
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3670576/
Abstract

Obesity is a major risk factor for insulin resistance and type 2 diabetes. Adipose tissue is now considered to be an active endocrine organ that secretes various adipokines such as adiponectin, leptin, resistin, tumour necrosis factor-α, and interleukin-6. Recent studies have shown that these factors might provide a molecular link between increased adiposity and impaired insulin sensitivity. Since hepatic insulin resistance plays the key role in the whole body insulin resistance, clarification of the regulatory processes about hepatic insulin resistance by adipokines in rodents and human would seem essential in order to understand the mechanism of type 2 diabetes and for developing novel therapeutic strategies to treat it.

摘要

肥胖是胰岛素抵抗和 2 型糖尿病的一个主要危险因素。脂肪组织现在被认为是一种活跃的内分泌器官,它分泌各种脂肪因子,如脂联素、瘦素、抵抗素、肿瘤坏死因子-α 和白细胞介素-6。最近的研究表明,这些因素可能为肥胖增加和胰岛素敏感性受损之间提供了一个分子联系。由于肝胰岛素抵抗在全身胰岛素抵抗中起着关键作用,因此了解脂肪因子在啮齿动物和人类中对肝胰岛素抵抗的调节过程,对于理解 2 型糖尿病的发病机制和开发治疗该病的新策略似乎是至关重要的。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4811/3670576/3414412b9f8a/JDR2013-170532.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4811/3670576/3414412b9f8a/JDR2013-170532.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4811/3670576/3414412b9f8a/JDR2013-170532.001.jpg

相似文献

1
Adipokines and hepatic insulin resistance.脂联素与肝胰岛素抵抗。
J Diabetes Res. 2013;2013:170532. doi: 10.1155/2013/170532. Epub 2013 May 16.
2
Role of Inflammatory Cytokines, Growth Factors and Adipokines in Adipogenesis and Insulin Resistance.炎症细胞因子、生长因子和脂肪因子在脂肪生成和胰岛素抵抗中的作用。
Inflammation. 2022 Feb;45(1):31-44. doi: 10.1007/s10753-021-01559-z. Epub 2021 Sep 18.
3
Molecular mechanisms of insulin resistance in diabetes.糖尿病中胰岛素抵抗的分子机制。
Adv Exp Med Biol. 2012;771:240-51. doi: 10.1007/978-1-4614-5441-0_19.
4
Association of Adipose Tissue and Adipokines with Development of Obesity-Induced Liver Cancer.脂肪组织和脂肪因子与肥胖相关性肝癌发展的相关性。
Int J Mol Sci. 2021 Feb 22;22(4):2163. doi: 10.3390/ijms22042163.
5
Advances in the Relationship between Adipokines and β-cell Failure in Type 2 Diabetes Mellitus.2型糖尿病中脂肪因子与β细胞功能衰竭关系的研究进展
Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2016 Oct 10;38(5):601-606. doi: 10.3881/j.issn.1000-503X.2016.05.020.
6
Adipokines: the missing link between insulin resistance and obesity.脂肪因子:胰岛素抵抗与肥胖之间缺失的环节。
Diabetes Metab. 2008 Feb;34(1):2-11. doi: 10.1016/j.diabet.2007.09.004.
7
Emerging Role of Adipocytokines in Type 2 Diabetes as Mediators of Insulin Resistance and Cardiovascular Disease.脂肪细胞因子在 2 型糖尿病中的新作用——作为胰岛素抵抗和心血管疾病的中介物。
Can J Diabetes. 2018 Aug;42(4):446-456.e1. doi: 10.1016/j.jcjd.2017.10.040. Epub 2017 Dec 8.
8
[Molecular mechanisms and correlations of insulin resistance, obesity, and type 2 diabetes mellitus].[胰岛素抵抗、肥胖与2型糖尿病的分子机制及相关性]
Orv Hetil. 2009 Apr 26;150(17):771-80. doi: 10.1556/OH.2009.28608.
9
Obesity, Bioactive Lipids, and Adipose Tissue Inflammation in Insulin Resistance.肥胖、生物活性脂质与胰岛素抵抗中的脂肪组织炎症
Nutrients. 2020 May 3;12(5):1305. doi: 10.3390/nu12051305.
10
[Pathophysiological characterization of metabolic syndrome in overweight, obese and type 2 diabetic Algerian subjects: interest of adipokines as dysmetabolic biomarkers].[阿尔及利亚超重、肥胖及2型糖尿病患者代谢综合征的病理生理特征:脂肪因子作为代谢紊乱生物标志物的意义]
Ann Biol Clin (Paris). 2014 Jul-Aug;72(4):463-72. doi: 10.1684/abc.2014.0980.

引用本文的文献

1
Experimental cell models of insulin resistance: overview and appraisal.胰岛素抵抗的实验性细胞模型:综述与评价
Front Endocrinol (Lausanne). 2024 Dec 19;15:1469565. doi: 10.3389/fendo.2024.1469565. eCollection 2024.
2
How Can Promoting Skeletal Muscle Health and Exercise in Children and Adolescents Prevent Insulin Resistance and Type 2 Diabetes?促进儿童和青少年骨骼肌健康及运动如何预防胰岛素抵抗和2型糖尿病?
Life (Basel). 2024 Sep 21;14(9):1198. doi: 10.3390/life14091198.
3
Serum and salivary adiponectin levels as predictive markers for diabetes mellitus in children with a family history of diabetes.

本文引用的文献

1
Effects of rosiglitazone treatment on insulin resistance and TNF-alpha levels in patients with chronic kidney disease: a prospective study.罗格列酮治疗对慢性肾脏病患者胰岛素抵抗和 TNF-α水平的影响:一项前瞻性研究。
Eur Rev Med Pharmacol Sci. 2012 Oct;16(11):1519-24.
2
Adiponectin action: a combination of endocrine and autocrine/paracrine effects.脂联素作用:内分泌和自分泌/旁分泌效应的结合。
Front Endocrinol (Lausanne). 2011 Nov 8;2:62. doi: 10.3389/fendo.2011.00062. eCollection 2011.
3
Combined use of serum adiponectin and tumor necrosis factor-alpha receptor 2 levels was comparable to 2-hour post-load glucose in diabetes prediction.
血清和唾液脂联素水平作为有糖尿病家族史儿童糖尿病的预测标志物。
J Med Life. 2023 Oct;16(10):1561-1565. doi: 10.25122/jml-2023-0023.
4
NADPH Dynamics: Linking Insulin Resistance and β-Cells Ferroptosis in Diabetes Mellitus.NADPH 动态:将胰岛素抵抗与糖尿病β细胞铁死亡联系起来。
Int J Mol Sci. 2023 Dec 26;25(1):342. doi: 10.3390/ijms25010342.
5
Endogenous and microbial biomarkers for periodontitis and type 2 diabetes mellitus.牙周炎和 2 型糖尿病的内源性和微生物生物标志物。
Front Endocrinol (Lausanne). 2023 Dec 5;14:1292596. doi: 10.3389/fendo.2023.1292596. eCollection 2023.
6
Fecal Metagenomics and Metabolomics Identifying Microbial Signatures in Non-Alcoholic Fatty Liver Disease.粪便宏基因组学和代谢组学鉴定非酒精性脂肪性肝病中的微生物特征。
Int J Mol Sci. 2023 Mar 2;24(5):4855. doi: 10.3390/ijms24054855.
7
Association between new markers of cardiovascular risk and hepatic insulin resistance in those at high risk of developing type 2 diabetes.新的心血管风险标志物与 2 型糖尿病高危人群肝胰岛素抵抗的相关性。
Endocrine. 2022 Feb;75(2):409-417. doi: 10.1007/s12020-021-02868-x. Epub 2021 Sep 21.
8
β-Sitosterol Circumvents Obesity Induced Inflammation and Insulin Resistance by down-Regulating IKKβ/NF-κB and JNK Signaling Pathway in Adipocytes of Type 2 Diabetic Rats.β-谷甾醇通过下调 2 型糖尿病大鼠脂肪细胞中 IKKβ/NF-κB 和 JNK 信号通路来规避肥胖引起的炎症和胰岛素抵抗。
Molecules. 2021 Apr 6;26(7):2101. doi: 10.3390/molecules26072101.
9
An Update to the WISP-1/CCN4 Role in Obesity, Insulin Resistance and Diabetes.WISP-1/CCN4 在肥胖、胰岛素抵抗和糖尿病中的作用的最新研究进展。
Medicina (Kaunas). 2021 Jan 23;57(2):100. doi: 10.3390/medicina57020100.
10
The Role of the Pentose Phosphate Pathway in Diabetes and Cancer.戊糖磷酸途径在糖尿病和癌症中的作用。
Front Endocrinol (Lausanne). 2020 Jun 9;11:365. doi: 10.3389/fendo.2020.00365. eCollection 2020.
联合使用血清脂联素和肿瘤坏死因子-α受体 2 水平与 2 小时负荷后血糖在糖尿病预测中的作用相当。
PLoS One. 2012;7(5):e36868. doi: 10.1371/journal.pone.0036868. Epub 2012 May 16.
4
Role of adipokines and other inflammatory mediators in gestational diabetes mellitus and previous gestational diabetes mellitus.脂联素和其他炎症介质在妊娠期糖尿病及既往妊娠期糖尿病中的作用。
Int J Endocrinol. 2012;2012:549748. doi: 10.1155/2012/549748. Epub 2012 Apr 9.
5
Association of TNF-α with insulin resistance in type 2 diabetes mellitus.肿瘤坏死因子-α与 2 型糖尿病胰岛素抵抗的相关性。
Indian J Med Res. 2012;135(1):127-30. doi: 10.4103/0971-5916.93435.
6
Insulin-sensitizing properties of adiponectin.脂联素的胰岛素增敏特性。
Biochimie. 2012 Oct;94(10):2131-6. doi: 10.1016/j.biochi.2012.01.017. Epub 2012 Jan 31.
7
Adiponectin, a key adipokine in obesity related liver diseases.脂联素,肥胖相关肝病中的关键脂肪因子。
World J Gastroenterol. 2011 Jun 21;17(23):2801-11. doi: 10.3748/wjg.v17.i23.2801.
8
Adiponectin enhances insulin sensitivity by increasing hepatic IRS-2 expression via a macrophage-derived IL-6-dependent pathway.脂联素通过巨噬细胞来源的 IL-6 依赖途径增加 IRS-2 在肝脏中的表达,从而增强胰岛素敏感性。
Cell Metab. 2011 Apr 6;13(4):401-412. doi: 10.1016/j.cmet.2011.02.010.
9
Chronic TNF-α neutralization does not improve insulin resistance or endothelial function in "healthy" men with metabolic syndrome.慢性 TNF-α 中和治疗不能改善代谢综合征“健康”男性的胰岛素抵抗和内皮功能。
Mol Med. 2011 Mar-Apr;17(3-4):189-93. doi: 10.2119/molmed.2010.00221. Epub 2010 Nov 16.
10
Adiponectin: a key player in obesity related disorders.脂联素:肥胖相关疾病的关键因素。
Curr Pharm Des. 2010 Jun;16(17):1896-901. doi: 10.2174/138161210791208893.